Yellow Oleander (Thevetia peruviana) Toxicity from a Misrepresented Dietary Supplement: A Case Report
Clinical Practice and Cases in Emergency Medicine · 06.08.2026 · 10 (3)
DOI: 10.5811/cpcem.54063 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Practice and Cases in Emergency Medicine, online erschienen am 06.08.2026. Verfasst von Samantha E Long und 3 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas Health Science Center at Houston, Department of Emergency Medicine, Houston, Texas. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The “lucky nut” is the seed of the yellow oleander plant, often sold as a medicinal supplement in unregulated markets and known to contain cardiac glycosides, which may cause life- threatening bradycardias and Digoxin-like toxicity upon ingestion. Diagnosis is typically clinical, with treatment including Digoxin immune Fab with supportive intensive cardiac care. Case Report: A 70-year-old male presented to the emergency department after ingesting one-fourth of a Peruvian nut he found at a local market to reduce his nocturnal polyuria. The patient brought a part of the Peruvian nut with him, which was identified as a seed of the yellow oleander. His clinical presentation was consistent with a digoxin-like toxicity, requiring multiple vials of Digoxin immune Fab and admission to the cardiac intensive care unit.
Conclusion
Yellow oleander can cause a cardiac glycoside-related cardiotoxicity similar to a digoxin-like toxicity. Digoxin-like toxicity should be considered in the bradycardic patient with a recent ingestion of a plant or seed. It is important to obtain a thorough history including medication reconciliation and supplement use. Despite well-documented dangers, yellow oleander continues to appear as an unregulated ingredient or contaminant in dietary supplements. This case highlights the severity of oleander toxicity, the challenge of managing digoxin-like cardiac glycoside poisoning, and the public health risk posed by unintentional ingestion of supplements containing yellow oleander.
Autor:innen und Institutionen
- The University of Texas Health Science Center at Houston, Department of Emergency Medicine, Houston, Texas.
Zitieren
APA
Long, S. E., Grim, A., Bhandari, S. K., & Zaidi, H. Q. (2026). Yellow Oleander (Thevetia peruviana) Toxicity from a Misrepresented Dietary Supplement: A Case Report. Clinical Practice and Cases in Emergency Medicine, 10(3). https://doi.org/10.5811/cpcem.54063
Vancouver
Long SE, Grim A, Bhandari SK, Zaidi HQ. Yellow Oleander (Thevetia peruviana) Toxicity from a Misrepresented Dietary Supplement: A Case Report. Clinical Practice and Cases in Emergency Medicine. 2026;10(3). doi:10.5811/cpcem.54063
BibTeX
@article{Long2026,
author = {Long, Samantha E and Grim, Allison and Bhandari, Salil K and Zaidi, Hashim Q},
title = {Yellow Oleander (Thevetia peruviana) Toxicity from a Misrepresented Dietary Supplement: A Case Report},
journal = {Clinical Practice and Cases in Emergency Medicine},
year = {2026},
volume = {10},
number = {3},
doi = {10.5811/cpcem.54063}
}
EUVIMED